To mitigate an intravenous (IV) fluid solution shortage, the Food and Drug Administration (FDA) announced a shelf life extension for eight IV solution products manufactured by Baxter Healthcare Corporation.
The critical shortage comes as the United States fights a severe flu epidemic and as Puerto Rico, where many IV solutions are produced, recovers from Hurricane Maria.
The FDA urges health care providers to store these products as labeled and squeeze IV solution bags prior to use to ensure there are no leaks. The agency discourages health care providers from relabeling the products with new, extended dates. If replacement products become available, the old products should be discarded.
Contact the FDA Center for Drug Evaluation and Research at email@example.com with questions regarding shelf life extensions.
Additional questions, please contact Director of Policy Erin O’Malley at firstname.lastname@example.org or 202.585.0127.